CompletedNot applicableNCT05416983

Developing a Shared Decision Making Tool for Patients With Surgically Removed Non-small Cell Lung Cancer

This study observes conversations between non-small cell lung cancer patients and their doctors to support the development of a decision aid that can be used to inform discussions about treatment options for after surgery. Patients who have undergone surgery for their non-small cell lung cancer may have the option of completing additional treatment. Patients contemplating this additional treatment have been shown to be most satisfied with their choice if they perceive an effort by their doctor to share decision making. Shared decision making tools can help doctors guide conversations, offer tailored recommendations, and support deliberation on whether or not to pursue treatment. This study develops a shared decision making tool for patients with surgically removed non-small cell lung cancer contemplating additional treatment.

Checked against the public recordLast updated Oct 30, 2025 · Source: ClinicalTrials.gov

StatusCompleted
PhaseNot applicable
U.S. locations1
SponsorMayo Clinic
01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
Mayo Clinic
Interventions being studied
Procedure: Discussion; Other: Questionnaire Administration
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

Inclusion Criteria: * PATIENTS: * Adults \>= 18 years with biopsy proven resected non-small cell lung cancer (NSCLC) * Appointments to discuss adjuvant treatment of resected NSCLC * CLINICIANS: * Clinicians who meet with patients to discuss adjuvant treatment of resected NSCLC * PAG MEMBERS: * Adults \>= 18 years * Member of the Knowledge and Evaluation Research (KER) Unit Patient Advisory Group (PAG) Exclusion Criteria: * PATIENTS * Major barriers to providing informed consent (i.e., dementia, severe hearing or visual impairment)

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Mayo Clinic in RochesterRochester, Minnesota

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Oct 30, 2025. Always confirm current availability with the study team.

View original record ↗